Barriers Persist To Implement Teplizumab In Clinical Practice
Pharmacy Times,
Type 1 diabetes (T1D) is caused by an immune-mediated destruction of pancreatic beta-cells.
Type 1 diabetes (T1D) is caused by an immune-mediated destruction of pancreatic beta-cells.
1. DiMeglio LA, Evans-Molina C, Oram RA. Type 1 diabetes. Lancet. 2018;391:2449–62.
Typ-1-Diabetes wird in Österreich bei Kindern und Jugendlichen häufiger. Die Behandlungstechnik, etwa bei Insulinpumpen-Systemen…